Plant-Derived Bioactive Compounds and Their Therapeutic Potential in Cancer
International Journal of Molecular Sciences · 11.05.2026 · 27 (10) · 4275
DOI: 10.3390/ijms27104275 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.05.2026. Verfasst von Martina Šemeláková und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, 040 11 Košice, Slovakia. Hauptthemen laut MEDLINE: Neoplasms, Phytochemicals, Antineoplastic Agents, Phytogenic, Plants. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science, Research and Sport of the Slovak Republic, Scientific Grant Agency of the Ministry of Education of the Slovak Republic, Slovak Grant Agency KEGA.
Abstract (Originalsprache)
Plant-derived bioactive compounds represent a major foundation of modern anticancer therapy and remain a prolific source of molecules with clinically relevant activity. This review provides an integrated classification of plant-derived anticancer compounds based on their clinical development status and predominant molecular mechanisms of action. Established chemotherapeutic agents, including taxanes, vinca alkaloids, and camptothecin derivatives, are distinguished from investigational phytochemicals such as polyphenols, flavonoids, terpenoids, and alkaloids that are under preclinical or clinical evaluation. These compounds target key hallmarks of cancer through modulation of microtubule dynamics, inhibition of topoisomerases, regulation of oncogenic signaling and epigenetic processes, and suppression of angiogenesis, invasion, and metastasis. Particular emphasis is placed on multitarget phytochemicals that interfere with PI3K/Akt, NF-κB, JAK/STAT, and MAPK pathways, induce apoptosis, and promote epigenetic reprogramming. In addition, major translational challenges, especially limited bioavailability, are discussed alongside advances in nano-enabled delivery systems designed to enhance therapeutic efficacy and reduce systemic toxicity. Collectively, this framework highlights the continuing relevance of plant-derived compounds in oncology and supports their rational integration into precision cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, 040 11 Košice, Slovakia.
ORCID-Profile: Martina Šemeláková, Terézia Hudáková, Peter Solár, Ján Šalagovič, Jozef Židzik
Förderung
- Ministry of Education, Science, Research and Sport of the Slovak Republic
- Scientific Grant Agency of the Ministry of Education of the Slovak Republic
- Slovak Grant Agency KEGA
Zitieren
APA
Šemeláková, M., Hudáková, T., Solár, P., Šalagovič, J., & Židzik, J. (2026). Plant-Derived Bioactive Compounds and Their Therapeutic Potential in Cancer. International Journal of Molecular Sciences, 27(10), 4275. https://doi.org/10.3390/ijms27104275
Vancouver
Šemeláková M, Hudáková T, Solár P, Šalagovič J, Židzik J. Plant-Derived Bioactive Compounds and Their Therapeutic Potential in Cancer. International Journal of Molecular Sciences. 2026;27(10):4275. doi:10.3390/ijms27104275
BibTeX
@article{emelkov2026,
author = {Šemeláková, Martina and Hudáková, Terézia and Solár, Peter and Šalagovič, Ján and Židzik, Jozef},
title = {Plant-Derived Bioactive Compounds and Their Therapeutic Potential in Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4275},
doi = {10.3390/ijms27104275}
}
EUVIMED